Lucid Diagnostics Inc (LUCD): Net earnings per share (EPS TTM)

Public company logo of Lucid Diagnostics (LUCD)

Physician confidence in esophageal cancer diagnostic methods strengthens the position of Lucid Diagnostics Inc. (LUCD). This 12-month net income per share chart demonstrates the current resilience of the business, where the metric stands at -0.47. The innovative EsoGuard test replaces endoscopy, simplifying screening. The company's strong pricing power is supported by the critical importance of early pathology detection via unique DNA analysis.

LUCD Lucid Diagnostics Inc. Net earnings per share for the last four quarters (07/04/2022 - 11/12/2026)

Summary analytical data breakdowns for Lucid Diagnostics, Inc. (LUCD)

- current quotes and average value forecast:
Price Chart Lucid Diagnostics Inc.|LUCD - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Lucid Diagnostics Inc.|LUCD - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Lucid Diagnostics|LUCD - Book Valuation of Business|Market Value to Book Value Ratio luciddx.com|LUCD - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Lucid Diagnostics Inc.|LUCD - Long-Term Debt to Capital|Short-Term Debt to Capital Lucid Diagnostics Inc|LUCD - Company Total Debt|Debts to Book Capitalization Lucid Diagnostics Inc.|LUCD - Long-Term Debt Volume|Company Short-Term Debts Lucid Diagnostics|Quick Liquidity Indicator luciddx.com
- earnings and multiples data:
LUCD - Final Profit|Projected Future Earnings Lucid Diagnostics Inc.|LUCD - Price to Earnings Multiple|Forward P/E Multiple Lucid Diagnostics|LUCD - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Lucid Diagnostics Inc.|LUCD - Operating profit EBITDA|Net earnings per share (EPS TTM) Lucid Diagnostics|LUCD - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months luciddx.com|LUCD - Earnings per share growth this year|Net earnings per share growth forecast for next year Lucid Diagnostics Inc.
Initial company analysis:Lucid Diagnostics Inc. (LUCD)
Flagship merchandise of Lucid Diagnostics, Inc.

The commercialization efficiency of EsoGuard tests for diagnosing precancerous esophageal conditions is directly reflected in the earnings per share dynamics of Lucid Diagnostics Inc. (LUCD). This calculation combines annual net income with the total number of issued shares, allowing for an assessment of the business's real profitability amid tight monetary policy. Analyzing the TTM annual earnings per share helps investors recognize the risk of overpaying for the asset in a timely manner.

Competitors of Lucid Diagnostics Inc.

A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Anbio Biotechnology (NNNN)|Earnings per share for the last twelve months SHC (soterahealth.com)|QuidelOrtho Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Inc OPK|CareDx Health - Net earnings per share (EPS TTM)|Maravai (MRVI) - Net earnings per share for the last 12 months|FLGT: Net earnings per share (EPS TTM)|LAB - Net earnings per share for the last four quarters|CTKB (Cytek Biosciences) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months OSUR (OraSure Technologies, Inc.)|Net earnings per share for the last 12 months XGN (Exagen Inc.)|MDXH (MDxHealth, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics)|IMDX: Earnings per share for the last 12 months|Trinity Biotech Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters ProPhase Labs Inc PRPH|AIMD: Net earnings per share (EPS TTM)|CoDx (CODX) - Net earnings per share (EPS TTM)|HSCS (Heart Test Laboratories) - Net earnings per share (EPS TTM)|BMRA - Net earnings per share for the trailing year|Earnings per share for the last twelve months Cardio Diagnostics (CDIO)|Onconetix Inc - Earnings per share for the last 12 months|Earnings per share for the last twelve months Virax Biolabs Group Ltd VRAX|Bluejay Diagnostics Corp (BJDX) - Net earnings per one share for the last twelve months|AWH - Earnings per share for the last twelve months|Net earnings per share for the last four quarters acceleratediagnostics.com AXDX|CNTG (Centogene N.V.) - Net earnings per share for the last 12 months|ENZ: Earnings per share for the last four quarters|FRES (Fresh2 Group Ltd) - Net earnings per share (EPS TTM)|GTG Labs (GENE) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) ME|Net earnings per share for the last 12 months psychemedics.com PMD